Cogent Biosciences Inc carried $222.9M in long-term debt against $312.0M in cash and equivalents at the end of fiscal year 2025. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Cogent Biosciences Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
COGT Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
COGT Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $223.5M+408.4% | $223.2M | $222.9M | $44.3M | $43.9M | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $181.2M+42.0% | $241.2M+91.4% | $312.0M+217.8% | $125.3M+29.1% | $127.6M+44.6% | $126.0M-41.6% | $98.2M+84.4% | $97.0M+11.8% | $88.2M-58.8% | $215.8M+34.3% | $53.2M-61.9% | $86.8M-38.2% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Cogent Biosciences Inc financials
Frequently Asked Questions
What was Cogent Biosciences Inc's long-term debt in fiscal year 2025?
Cogent Biosciences Inc carried $222.9M in long-term debt against $312.0M in cash and equivalents at the end of fiscal year 2025.
What was Cogent Biosciences Inc's long-term debt in the most recent quarter?
Cogent Biosciences Inc (COGT) reported $223.5M in long-term debt in Q2 2026. This represents an increase of 408.4% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Cogent Biosciences Inc (COGT) reported on that line in every period on record.